Netherlands Biotechnology & Medical Research

NewAmsterdam Pharma Company N.V. (NAMS)

Track

Track

NewAmsterdam Pharma experienced significant selling pressure recently, with insiders offloading over 17 million dollars in stock. Despite this trend, the CEO initiated a purchase of 226,500 dollars. These transactions follow a period of declining share prices and a recent miss in the latest earnings report, reflecting notable activity among key leadership figures.
Ticker: NAMS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for NewAmsterdam Pharma Company N.V.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
226.83
Quantity 14,082 +26.4%
Value US$4,513,074
2.9
Smither John W Non-Executive Director
Transaction date
Sale
Price
15.53
Quantity 8,880 -19.3%
Value US$330,720
2.4
Kastelein Johannes Jacob Pieter Chief Scientific Officer Executive Director
Transaction date
Sale
Price
26.91
Quantity 125,000 -64.3%
Value US$3,363,750
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
31.71
Quantity 2,915 -10.7%
Value US$92,435
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
31.05
Quantity 31,885 -53.9%
Value US$990,029
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
29.96
Quantity 70,200 -54.3%
Value US$2,103,192
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
30.73
Quantity 300 -1.2%
Value US$9,219
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
30.20
Quantity 39,700 -61.7%
Value US$1,198,940
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
35.69
Quantity 65,000 -72.7%
Value US$2,319,850
3.0
Louise Kooij Officer Officer
Transaction date
Proposed sale
Price
35.44
Quantity 210,000
Value US$7,442,400
2.2
LANGE LOUIS G Non-Executive Director
Transaction date
Sale
Price
31.23
Quantity 446 -4.1%
Value US$13,929
2.2
LANGE LOUIS G Non-Executive Director
Transaction date
Sale
Price
30.41
Quantity 44,173 -80.3%
Value US$1,343,301
2.2
Louis G. Lange Affiliate
Transaction date
Proposed sale
Price
31.27
Quantity 44,619
Value US$1,395,236
2.2
LANGE LOUIS G Non-Executive Director
Transaction date
Sale
Price
29.41
Quantity 28,186 -100.0%
Value US$828,950
2.2
Louis G. Lange Affiliate
Transaction date
Proposed sale
Price
31.18
Quantity 28,186
Value US$878,839
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Sale
Price
33.25
Quantity 443,707 -71.8%
Value US$14,753,258
3.1
Michael H. Davidson Affiliate
Transaction date
Proposed sale
Price
35.46
Quantity 443,707
Value US$15,733,850
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Sale
Price
34.44
Quantity 17,924 -9.3%
Value US$617,303
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Sale
Price
33.63
Quantity 165,408 -25.7%
Value US$5,562,671
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.68
Quantity 1,300 -0.3%
Value US$47,684
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Sale
Price
35.96
Quantity 10,436 -2.2%
Value US$375,279
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Sale
Price
35.11
Quantity 46,517 -9.0%
Value US$1,633,212
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.46
Quantity 3,161 -0.7%
Value US$115,250
3.1
Davidson Michael H. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.13
Quantity 61,547 -11.7%
Value US$2,223,693
3.1
Michael H. Davidson Affiliate
Transaction date
Proposed sale
Price
36.17
Quantity 750,000
Value US$27,127,500
2.4
Kastelein Johannes Jacob Pieter Officer; Director Executive Director
Transaction date
Proposed sale
Price
34.63
Quantity 45,481
Value US$1,575,007
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
31.80
Quantity 32,612 -57.2%
Value US$1,037,062
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
32.62
Quantity 39,816 -62.0%
Value US$1,298,798
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
33.45
Quantity 309 -1.3%
Value US$10,336
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
32.77
Quantity 34,091 -58.0%
Value US$1,117,162
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
34.37
Quantity 12,767 -34.4%
Value US$438,802
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
33.44
Quantity 25,405 -40.6%
Value US$849,543
2.2
Somaiya Mayur Ian Chief Financial Officer Officer
Transaction date
Planned sale
Price
33.80
Quantity 24,362 -29.4%
Value US$823,436
2.2
Somaiya Mayur Ian Chief Financial Officer Officer
Transaction date
Planned sale
Price
33.25
Quantity 15,422 -15.7%
Value US$512,782
2.2
Somaiya Mayur Ian Chief Financial Officer Officer
Transaction date
Planned sale
Price
32.38
Quantity 19,604 -25.1%
Value US$634,778
2.2
Somaiya Mayur Ian Chief Financial Officer Officer
Transaction date
Planned sale
Price
31.78
Quantity 39,712 -33.7%
Value US$1,262,047
2.2
Somaiya Mayur Ian Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.64
Quantity 900 -0.8%
Value US$27,576
2.2
Mayur Somaiya Affiliate
Transaction date
Proposed sale
Price
31.65
Quantity 200,000
Value US$6,330,000
3.1
Michael Davidson affiliate
Transaction date
Proposed sale
Price
35.48
Quantity 11,582
Value US$410,889
Douglas F Kling Affiliate
Transaction date
Proposed sale
Price
33.48
Quantity 300,000
Value US$10,044,000
2.2
Somaiya Mayur Ian Chief Financial Officer Officer
Transaction date
Sale
Price
33.25
Quantity 5,118 -13.5%
Value US$170,174
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
33.25
Quantity 2,647 -17.6%
Value US$88,013
3.0
Louise Kooij affiliate
Transaction date
Proposed sale
Price
33.25
Quantity 2,647
Value US$88,012
2.4
Johannes Kastelein Affiliate
Transaction date
Proposed sale
Price
33.25
Quantity 6,000
Value US$199,499
2.2
Mayur Ian Somaiya affiliate
Transaction date
Proposed sale
Price
33.25
Quantity 5,118
Value US$170,173
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
35.30
Quantity 43,872 -74.5%
Value US$1,548,682
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
35.68
Quantity 26,011 -63.4%
Value US$928,072
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
36.21
Quantity 75,117 -83.4%
Value US$2,719,987
3.0
Louise Kooij Officer Officer
Transaction date
Proposed sale
Price
36.49
Quantity 290,000
Value US$10,582,100
BCLS II Investco, LP Former Affiliate
Transaction date
Proposed sale
Price
38.33
Quantity 4,500,000
Value US$172,485,000
3.7
Topper James N Non-Executive Director
Transaction date
Purchase
Price
23.70
Quantity 660 +0.0%
Value US$15,639
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
26.11
Quantity 96,896 -86.6%
Value US$2,529,955
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
25.31
Quantity 53,104 -32.2%
Value US$1,344,062
3.0
Louise Kooij Affiliate
Transaction date
Proposed sale
Price
25.20
Quantity 150,000
Value US$3,780,000
3.7
Topper James N Non-Executive Director
Transaction date
Purchase
Price
24.99
Quantity 1,260 +0.0%
Value US$31,487
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
25.09
Quantity 18,073 -54.6%
Value US$453,452
3.0
Kooij Louise Frederika Officer Officer
Transaction date
Proposed sale
Price
24.05
Quantity 18,073
Value US$434,656
3.0
Kooij Louise Frederika Officer Officer
Transaction date
Proposed sale
Price
25.19
Quantity 8,269
Value US$208,296
3.0
Kooij Louise Frederika Chief Accounting Officer Officer
Transaction date
Sale
Price
24.86
Quantity 8,269 -35.5%
Value US$205,567
2.4
Kastelein Johannes Jacob Pieter Officer; Director Executive Director
Transaction date
Proposed sale
Price
25.00
Quantity 100,000
Value US$2,500,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-09-30 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
37,473 -23.4%
493.80
US$3,585,260 		37,473 -23.4% 493.80 US$3,585,260
2026-09-15 2026-09-14 B Purchase
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
14,082 +26.4%
226.83
US$4,513,074 		14,082 +26.4% 226.83 US$4,513,074
2026-09-09 2026-09-04 S Sale
2.9
Smither John W
Non-Executive Director
8,880 -19.3%
15.53
US$330,720 		8,880 -19.3% 15.53 US$330,720
2026-08-25 2026-08-25 PrS Proposed sale
2.4
Kastelein Johannes Jacob Pieter

Affiliate
250,000
27.87
US$6,967,500 		250,000 27.87 US$6,967,500
2026-08-25 2026-08-24 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
125,000 -64.3%
26.91
US$3,363,750 		125,000 -64.3% 26.91 US$3,363,750
2026-08-24 2026-08-24 PrS Proposed sale
2.4
Kastelein Johannes Jacob Pieter

Affiliate
125,000
27.87
US$3,483,750 		125,000 27.87 US$3,483,750
2026-07-22 2026-07-20 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
2,915 -10.7%
31.71
US$92,435 		2,915 -10.7% 31.71 US$92,435
2026-07-22 2026-07-20 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
31,885 -53.9%
31.05
US$990,029 		31,885 -53.9% 31.05 US$990,029
2026-07-22 2026-07-20 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
70,200 -54.3%
29.96
US$2,103,192 		70,200 -54.3% 29.96 US$2,103,192
2026-06-24 2026-06-22 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
300 -1.2%
30.73
US$9,219 		300 -1.2% 30.73 US$9,219
2026-06-24 2026-06-22 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
39,700 -61.7%
30.20
US$1,198,940 		39,700 -61.7% 30.20 US$1,198,940
2026-05-27 2026-05-26 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
65,000 -72.7%
35.69
US$2,319,850 		65,000 -72.7% 35.69 US$2,319,850
2026-05-26 2026-05-26 PrS Proposed sale
3.0
Louise Kooij

Officer

Officer
210,000
35.44
US$7,442,400 		210,000 35.44 US$7,442,400
2026-03-12 2026-03-11 S Sale
2.2
LANGE LOUIS G
Non-Executive Director
446 -4.1%
31.23
US$13,929 		446 -4.1% 31.23 US$13,929
2026-03-12 2026-03-11 S Sale
2.2
LANGE LOUIS G
Non-Executive Director
44,173 -80.3%
30.41
US$1,343,301 		44,173 -80.3% 30.41 US$1,343,301
2026-03-11 2026-03-11 PrS Proposed sale
2.2
Louis G. Lange

Affiliate
44,619
31.27
US$1,395,236 		44,619 31.27 US$1,395,236
2026-03-09 2026-03-09 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
101,409 -59.4%
30.29
US$3,071,679 		101,409 -59.4% 30.29 US$3,071,679
2026-03-10 2026-03-06 S Sale
2.2
LANGE LOUIS G
Non-Executive Director
28,186 -100.0%
29.41
US$828,950 		28,186 -100.0% 29.41 US$828,950
2026-03-09 2026-03-06 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
94,124 -57.6%
30.32
US$2,853,840 		94,124 -57.6% 30.32 US$2,853,840
2026-03-06 2026-03-06 PrS Proposed sale
2.2
Louis G. Lange

Affiliate
28,186
31.18
US$878,839 		28,186 31.18 US$878,839
2026-03-09 2026-03-05 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
104,467 -60.1%
30.30
US$3,165,350 		104,467 -60.1% 30.30 US$3,165,350
2026-03-05 2026-03-02 PrS Proposed sale
2.4
Kastelein Johannes Jacob Pieter

Affiliate
300,000
31.18
US$9,354,000 		300,000 31.18 US$9,354,000
2026-03-02 2026-03-02 S Sale
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
443,707 -71.8%
33.25
US$14,753,258 		443,707 -71.8% 33.25 US$14,753,258
2026-03-02 2026-03-02 PrS Proposed sale
3.1
Michael H. Davidson

Affiliate
443,707
35.46
US$15,733,850 		443,707 35.46 US$15,733,850
2026-02-26 2026-02-26 S Sale
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
17,924 -9.3%
34.44
US$617,303 		17,924 -9.3% 34.44 US$617,303
2026-02-26 2026-02-26 S Sale
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
165,408 -25.7%
33.63
US$5,562,671 		165,408 -25.7% 33.63 US$5,562,671
2026-02-26 2026-02-25 S Sale
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
1,300 -0.3%
36.68
US$47,684 		1,300 -0.3% 36.68 US$47,684
2026-02-26 2026-02-25 S Sale
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
10,436 -2.2%
35.96
US$375,279 		10,436 -2.2% 35.96 US$375,279
2026-02-26 2026-02-25 S Sale
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
46,517 -9.0%
35.11
US$1,633,212 		46,517 -9.0% 35.11 US$1,633,212
2026-02-26 2026-02-24 S Sale
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
3,161 -0.7%
36.46
US$115,250 		3,161 -0.7% 36.46 US$115,250
2026-02-26 2026-02-24 S Sale
3.1
Davidson Michael H.

Chief Executive Officer

Executive Director
61,547 -11.7%
36.13
US$2,223,693 		61,547 -11.7% 36.13 US$2,223,693
2026-02-24 2026-02-24 PrS Proposed sale
3.1
Michael H. Davidson

Affiliate
750,000
36.17
US$27,127,500 		750,000 36.17 US$27,127,500
2026-02-24 2026-02-20 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
30,789 -36.5%
35.46
US$1,091,778 		30,789 -36.5% 35.46 US$1,091,778
2026-02-24 2026-02-20 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
14,692 -14.8%
35.00
US$514,220 		14,692 -14.8% 35.00 US$514,220
2026-02-20 2026-02-20 PrS Proposed sale
2.4
Kastelein Johannes Jacob Pieter

Officer; Director

Executive Director
45,481
34.63
US$1,575,007 		45,481 34.63 US$1,575,007
2026-01-29 2026-01-28 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
32,612 -57.2%
31.80
US$1,037,062 		32,612 -57.2% 31.80 US$1,037,062
2026-01-29 2026-01-27 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
39,816 -62.0%
32.62
US$1,298,798 		39,816 -62.0% 32.62 US$1,298,798
2026-01-27 2026-01-26 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
309 -1.3%
33.45
US$10,336 		309 -1.3% 33.45 US$10,336
2026-01-27 2026-01-26 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
34,091 -58.0%
32.77
US$1,117,162 		34,091 -58.0% 32.77 US$1,117,162
2026-01-27 2026-01-23 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
12,767 -34.4%
34.37
US$438,802 		12,767 -34.4% 34.37 US$438,802
2026-01-27 2026-01-23 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
25,405 -40.6%
33.44
US$849,543 		25,405 -40.6% 33.44 US$849,543
2026-01-22 2026-01-21 PlS Planned sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
24,362 -29.4%
33.80
US$823,436 		24,362 -29.4% 33.80 US$823,436
2026-01-22 2026-01-21 PlS Planned sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
15,422 -15.7%
33.25
US$512,782 		15,422 -15.7% 33.25 US$512,782
2026-01-22 2026-01-20 PlS Planned sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
19,604 -25.1%
32.38
US$634,778 		19,604 -25.1% 32.38 US$634,778
2026-01-22 2026-01-20 PlS Planned sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
39,712 -33.7%
31.78
US$1,262,047 		39,712 -33.7% 31.78 US$1,262,047
2026-01-22 2026-01-20 PlS Planned sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
900 -0.8%
30.64
US$27,576 		900 -0.8% 30.64 US$27,576
2026-01-20 2026-01-20 PrS Proposed sale
2.2
Mayur Somaiya

Affiliate
200,000
31.65
US$6,330,000 		200,000 31.65 US$6,330,000
2026-01-07 2026-01-07 PrS Proposed sale
3.1
Michael Davidson

affiliate
11,582
35.48
US$410,889 		11,582 35.48 US$410,889
2026-01-06 2026-01-06 PrS Proposed sale
Douglas F Kling

Affiliate
300,000
33.48
US$10,044,000 		300,000 33.48 US$10,044,000
2026-01-07 2026-01-05 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
6,000 -7.5%
33.25
US$199,500 		6,000 -7.5% 33.25 US$199,500
2026-01-07 2026-01-05 S Sale
2.2
Somaiya Mayur Ian

Chief Financial Officer

Officer
5,118 -13.5%
33.25
US$170,174 		5,118 -13.5% 33.25 US$170,174
2026-01-07 2026-01-05 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
2,647 -17.6%
33.25
US$88,013 		2,647 -17.6% 33.25 US$88,013
2026-01-05 2026-01-05 PrS Proposed sale
3.0
Louise Kooij

affiliate
2,647
33.25
US$88,012 		2,647 33.25 US$88,012
2026-01-05 2026-01-05 PrS Proposed sale
2.4
Johannes Kastelein

Affiliate
6,000
33.25
US$199,499 		6,000 33.25 US$199,499
2026-01-05 2026-01-05 PrS Proposed sale
2.2
Mayur Ian Somaiya

affiliate
5,118
33.25
US$170,173 		5,118 33.25 US$170,173
2025-12-29 2025-12-26 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
43,872 -74.5%
35.30
US$1,548,682 		43,872 -74.5% 35.30 US$1,548,682
2025-12-29 2025-12-24 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
26,011 -63.4%
35.68
US$928,072 		26,011 -63.4% 35.68 US$928,072
2025-12-29 2025-12-23 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
75,117 -83.4%
36.21
US$2,719,987 		75,117 -83.4% 36.21 US$2,719,987
2025-12-23 2025-12-23 PrS Proposed sale
3.0
Louise Kooij

Officer

Officer
290,000
36.49
US$10,582,100 		290,000 36.49 US$10,582,100
2025-12-02 2025-12-02 PrS Proposed sale
Bain Capital Life Sciences Fund II, L.P.

Former Affiliate
267,429
38.33
US$10,250,554 		267,429 38.33 US$10,250,554
2025-12-02 2025-12-02 PrS Proposed sale
BCLS II Investco, LP

Former Affiliate
4,500,000
38.33
US$172,485,000 		4,500,000 38.33 US$172,485,000
2025-12-02 2025-12-02 PrS Proposed sale
BCIP Life Sciences Associates, LP

Former Affiliate
32,571
38.33
US$1,248,446 		32,571 38.33 US$1,248,446
2025-09-17 2025-09-15 B Purchase
3.7
Topper James N
Non-Executive Director
660 +0.0%
23.70
US$15,639 		660 +0.0% 23.70 US$15,639
2025-09-10 2025-09-09 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
96,896 -86.6%
26.11
US$2,529,955 		96,896 -86.6% 26.11 US$2,529,955
2025-09-10 2025-09-09 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
53,104 -32.2%
25.31
US$1,344,062 		53,104 -32.2% 25.31 US$1,344,062
2025-09-09 2025-09-09 PrS Proposed sale
3.0
Louise Kooij

Affiliate
150,000
25.20
US$3,780,000 		150,000 25.20 US$3,780,000
2025-09-10 2025-09-08 B Purchase
3.7
Topper James N
Non-Executive Director
1,260 +0.0%
24.99
US$31,487 		1,260 +0.0% 24.99 US$31,487
2025-09-05 2025-09-03 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
18,073 -54.6%
25.09
US$453,452 		18,073 -54.6% 25.09 US$453,452
2025-09-03 2025-09-03 PrS Proposed sale
3.0
Kooij Louise Frederika

Officer

Officer
18,073
24.05
US$434,656 		18,073 24.05 US$434,656
2025-08-27 2025-08-25 PrS Proposed sale
3.0
Kooij Louise Frederika

Officer

Officer
8,269
25.19
US$208,296 		8,269 25.19 US$208,296
2025-08-27 2025-08-25 S Sale
3.0
Kooij Louise Frederika

Chief Accounting Officer

Officer
8,269 -35.5%
24.86
US$205,567 		8,269 -35.5% 24.86 US$205,567
2025-08-25 2025-08-22 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
7,658 -10.0%
25.49
US$195,202 		7,658 -10.0% 25.49 US$195,202
2025-08-25 2025-08-22 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
42,342 -35.5%
25.08
US$1,061,937 		42,342 -35.5% 25.08 US$1,061,937
2025-08-25 2025-08-21 PrS Proposed sale
2.4
Kastelein Johannes Jacob Pieter

Officer; Director

Executive Director
100,000
25.00
US$2,500,000 		100,000 25.00 US$2,500,000
2025-08-25 2025-08-21 S Sale
2.4
Kastelein Johannes Jacob Pieter

Chief Scientific Officer

Executive Director
50,000 -29.5%
24.29
US$1,214,500 		50,000 -29.5% 24.29 US$1,214,500
Explore more

More insider trading research around NewAmsterdam Pharma Company N.V.

More insider trades in Netherlands
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe